Q&A

Favorable response to proton pump inhibitors doesn’t necessarily diagnose GERD

Author and Disclosure Information

  • CLINICAL QUESTION: If patients respond to treatment with proton pump inhibitors, does that mean that they have gastroesophageal reflux disease?
  • STUDY DESIGN: Meta-analysis (randomized controlled trials)
  • SETTING: Various (meta-analysis)
  • SYNOPSIS: Several guidelines on the treatment of gastroesophageal reflux disease (GERD) suggest lifestyle changes and treatment with acid-suppressive therapy as the first-line approach. A favorable response to therapy with a proton pump inhibitor (PPI) often is used as confirmation of the diagnosis (the PPI test).


 

BOTTOM LINE

Response to treatment with a proton pump inhibitor does not identify patients as having gastroesophageal reflux disease. As a result, an initial response should not consign the patient to long-term therapy. These results agree with other research showing that patients can use short-term treatment (2 weeks), stop treatment, and then begin treatment again if symptoms recur, which won’t happen in approximately half of them (BMJ 1999; 318:502–507). (LOE=1a)

Recommended Reading

Laparoscopic cholecystectomy in a rural family practice: The Vivian, LA, experience
MDedge Family Medicine
What regimens eradicate Heliobacter pylori?
MDedge Family Medicine
Does breastfeeding protect against viral GI infections in children
MDedge Family Medicine
Gastroesophageal Reflux Disease
MDedge Family Medicine
Analgesics do not interfere with diagnosing abdominal pain
MDedge Family Medicine
Ephedra and ephedrine: Modest short-term weight loss, with a price
MDedge Family Medicine
Taper proton pump inhibitor to once daily for GERD
MDedge Family Medicine
Anticholinergics reduce symptoms of overactive bladder
MDedge Family Medicine
Extended-release oxybutynin and tolterodine treat overactive bladder
MDedge Family Medicine
Omeprazole and placebo have same long-term effect on dyspepsia
MDedge Family Medicine